NCT03259464View on ClinicalTrials.gov

This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 4, 2017

Primary Completion Date

May 26, 2018

Study Completion Date

May 26, 2018

Conditions
Healthy
Interventions
DRUG

BI 685509

3 sequential dose groups

DRUG

Placebo

3 sequential dose groups

Trial Locations (2)

133-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03259464 - This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated | Biotech Hunter | Biotech Hunter